Physician profile
Mark A Hillyer
NPI 1649248840
$771.04
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $657 · 2020: $97.66 · 2023: $16.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $149.65 | 2019-2023 | Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $109.31 | 2019 | |
| Amgen INC. | $75.56 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $52.07 | 2019 | |
| Pfizer INC. | $49.29 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $48.20 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.59 | 2019-2020 | |
| Lilly USA, LLC | $36.09 | 2019-2020 | |
| Radius Health, INC. | $26.59 | 2019 | |
| Novartis Pharmaceuticals Corporation | $23.45 | 2019 | |
| Merck Sharp & Dohme LLC | $22.38 | 2019 | |
| Glaxosmithkline, LLC. | $22.11 | 2019 | |
| Ironshore Pharmaceuticals INC. | $19.18 | 2019 | |
| Jazz Pharmaceuticals INC. | $17.54 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.05 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $14.69 | 2019 | |
| Amarin Pharma, INC. | $14.45 | 2019 | |
| Shire North American Group INC | $12.25 | 2019 | |
| Janssen Pharmaceuticals, INC | $12.19 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $11.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Hillyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.